Neuren Pharmaceuticals LimitedASX: NEU

NEU confirms primary endpoints for Phase 3 trial in PMS

Apr 14, 2025 at 3:19 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment